Literature DB >> 28527220

Quantitative Erythrocyte Omega-3 EPA Plus DHA Levels are Related to Higher Regional Cerebral Blood Flow on Brain SPECT.

Daniel G Amen1, William S Harris2, Parris M Kidd1, Somayeh Meysami3, Cyrus A Raji4.   

Abstract

BACKGROUND: The interrelationships between omega-3 fatty acids status, brain perfusion, and cognition are not well understood.
OBJECTIVE: To evaluate if SPECT brain imaging of cerebral perfusion and cognition varies as a function of omega-3 fatty acid levels.
METHODS: A random sample of 166 study participants was drawn from a psychiatric referral clinical for which erythrocyte quantification of omega-3 eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) (the Omega-3 Index) was available. Quantitative brain SPECT was done on 128 regions based on a standard anatomical Atlas. Persons with erythrocyte EPA+DHA concentrations were dichotomized based on membership in top 50th percentile versus bottom 50th percentile categories. Two-sample t-tests were done to identify statistically significant differences in perfusion between the percentile groups. Partial correlations were modeled between EPA+DHA concentration and SPECT regions. Neurocognitive status was assessed using computerized testing (WebNeuro) and was separately correlated to cerebral perfusion on brain SPECT imaging and omega-3 EPA+DHA levels.
RESULTS: Partial correlation analyses showed statistically significant relationships between higher omega-3 levels and cerebral perfusion were in the right parahippocampal gyrus (r = 0.20, p = 0.03), right precuneus (r = 0.20, p = 0.03), and vermis subregion 6 (p = 0.21, p = 0.03). Omega-3 Index levels separately correlated to the feeling subsection of the WebNeuro (r = 0.25, p = 0.01).
CONCLUSION: Quantitative omega-3 EPA+DHA erythrocyte concentrations are independently correlated with brain perfusion on SPECT imaging and neurocognitive tests. These results have implications for the role of omega-3 fatty acids toward contributing to cognitive reserve.

Entities:  

Keywords:  Brain SPECT; cognitive; omega-3

Mesh:

Substances:

Year:  2017        PMID: 28527220     DOI: 10.3233/JAD-170281

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  6 in total

1.  Effects of Docosahexaenoic Acid and Its Peroxidation Product on Amyloid-β Peptide-Stimulated Microglia.

Authors:  Xue Geng; Bo Yang; Runting Li; Tao Teng; Mary Jo Ladu; Grace Y Sun; C Michael Greenlief; James C Lee
Journal:  Mol Neurobiol       Date:  2019-11-01       Impact factor: 5.590

Review 2.  Immunotherapy of Mild Cognitive Impairment by ω-3 Supplementation: Why Are Amyloid-β Antibodies and ω-3 Not Working in Clinical Trials?

Authors:  Milan Fiala; Lucas Restrepo; Matteo Pellegrini
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Self-Reported Omega-3 Supplement Use Moderates the Association between Age and Exercising Cerebral Blood Flow Velocity in Older Adults.

Authors:  Carolyn S Kaufman; Eric D Vidoni; Jeffrey M Burns; Mohammed R Alwatban; Sandra A Billinger
Journal:  Nutrients       Date:  2020-03-05       Impact factor: 5.717

4.  Patterns of Regional Cerebral Blood Flow as a Function of Obesity in Adults.

Authors:  Daniel G Amen; Joseph Wu; Noble George; Andrew Newberg
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 5.  Importance of EPA and DHA Blood Levels in Brain Structure and Function.

Authors:  Clemens von Schacky
Journal:  Nutrients       Date:  2021-03-25       Impact factor: 5.717

6.  US Family Physicians Overestimate Personal ω-3 Fatty Acid Biomarker Status: Associations with Fatty Fish and ω-3 Supplement Intake.

Authors:  Nathan V Matusheski; Keri Marshall; Sonia Hartunian-Sowa; Michael I McBurney
Journal:  Curr Dev Nutr       Date:  2017-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.